NMT2 and diffuse large B-cell lymphoma: By doing so, we developed PCLX-001 resistant BL2 cells with a twofold higher PCLX-001 EC50 of 56 nM (p = 0.04), which was associated with a 72% increase in NMT2 protein levels (Fig. 4B–D; similar results were obtained with the DLBCL DOHH2 cell line in Additional file 1: Fig. S18).